1. Home
  2. XOMAP vs MANH Comparison

XOMAP vs MANH Comparison

Compare XOMAP & MANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMAP

XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

HOLD

Current Price

$25.75

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Logo Manhattan Associates Inc.

MANH

Manhattan Associates Inc.

HOLD

Current Price

$127.13

Market Cap

9.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XOMAP
MANH
Founded
N/A
1990
Country
United States
United States
Employees
13
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
9.0B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
XOMAP
MANH
Price
$25.75
$127.13
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$222.18
AVG Volume (30 Days)
860.0
555.7K
Earning Date
N/A
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.56
EPS
N/A
3.60
Revenue
N/A
$131,300,000.00
Revenue This Year
N/A
$8.10
Revenue Next Year
N/A
$8.81
P/E Ratio
N/A
$36.76
Revenue Growth
N/A
N/A
52 Week Low
$24.96
$127.35
52 Week High
$27.11
$247.22

Technical Indicators

Market Signals
Indicator
XOMAP
MANH
Relative Strength Index (RSI) 43.80 34.37
Support Level $25.54 N/A
Resistance Level $25.92 $180.67
Average True Range (ATR) 0.06 5.16
MACD 0.01 -0.98
Stochastic Oscillator 48.72 4.71

Price Performance

Historical Comparison
XOMAP
MANH

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About MANH Manhattan Associates Inc.

Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers worldwide.

Share on Social Networks: